Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Valentini

Showing results (111-120 of 143) with videos related to

Pageof 15
Sort By:
Clinical and Experimental Rheumatology|August 6, 2013
Pulmonary hypertension in systemic sclerosis: prevalence, incidence and predictive factors in a large multicentric Italian cohortMichele Iudici, Veronica Codullo, Dilia Giuggioli, et al.
The Journal of Rheumatology|June 3, 2009
Serologic profile and mortality rates of scleroderma renal crisis in ItalyVeronica Codullo, Ilaria Cavazzana, Claudia Bonino, et al.
Autoimmunity Reviews|July 20, 2019
Undifferentiated connective tissue disease at risk of systemic sclerosis: A weighted score to identify patients who will evolveAntonella Riccardi, Antonella Marcoccia, Alessia Borgia, et al.
Chest|October 16, 2022
Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and ResearchAnna-Maria Hoffmann-Vold, Cathrine Brunborg, Paolo Airò, et al.
Arthritis Research & Therapy|July 11, 2014
Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot studyPaolo Fraticelli, Barbara Gabrielli, Giovanni Pomponio, et al.
Medicine|October 20, 2017
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) studyPiero Ruscitti, Domenico Paolo Emanuele Margiotta, Federica Macaluso, et al.
Arthritis Research & Therapy|February 1, 2018
Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR groupSabine Adler, Dörte Huscher, Elise Siegert, et al.
Arthritis and Rheumatism|October 23, 2010
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosisMirko Manetti, Yannick Allanore, Lucile Revillod, et al.
The Journal of Rheumatology|April 13, 2002
Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosisRoberto Giacomelli, Gabriele Valentini, Felice Salsano, et al.
Annals of the Rheumatic Diseases|May 13, 2017
Elevated serum levels of sonic hedgehog are associated with fibrotic and vascular manifestations in systemic sclerosisChristian Beyer, Dörte Huscher, Andreas Ramming, et al.
Pageof 15

Showing results (111-120 of 143) with videos related to

Sort By:
Pageof 15
Clinical and Experimental Rheumatology|August 6, 2013
Pulmonary hypertension in systemic sclerosis: prevalence, incidence and predictive factors in a large multicentric Italian cohortMichele Iudici, Veronica Codullo, Dilia Giuggioli, et al.
The Journal of Rheumatology|June 3, 2009
Serologic profile and mortality rates of scleroderma renal crisis in ItalyVeronica Codullo, Ilaria Cavazzana, Claudia Bonino, et al.
Autoimmunity Reviews|July 20, 2019
Undifferentiated connective tissue disease at risk of systemic sclerosis: A weighted score to identify patients who will evolveAntonella Riccardi, Antonella Marcoccia, Alessia Borgia, et al.
Chest|October 16, 2022
Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and ResearchAnna-Maria Hoffmann-Vold, Cathrine Brunborg, Paolo Airò, et al.
Arthritis Research & Therapy|July 11, 2014
Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot studyPaolo Fraticelli, Barbara Gabrielli, Giovanni Pomponio, et al.
Medicine|October 20, 2017
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) studyPiero Ruscitti, Domenico Paolo Emanuele Margiotta, Federica Macaluso, et al.
Arthritis Research & Therapy|February 1, 2018
Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR groupSabine Adler, Dörte Huscher, Elise Siegert, et al.
Arthritis and Rheumatism|October 23, 2010
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosisMirko Manetti, Yannick Allanore, Lucile Revillod, et al.
The Journal of Rheumatology|April 13, 2002
Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosisRoberto Giacomelli, Gabriele Valentini, Felice Salsano, et al.
Annals of the Rheumatic Diseases|May 13, 2017
Elevated serum levels of sonic hedgehog are associated with fibrotic and vascular manifestations in systemic sclerosisChristian Beyer, Dörte Huscher, Andreas Ramming, et al.
Pageof 15